Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
23andme
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bio
biology
biotech
bluebird bio
boston
boston blog main
boston top stories
clinical trials
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
food and drug administration
gene therapy
genetic testing
health
joshua brumm
kaleido biosciences
life sciences
medicine
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
romesh subramanian
san diego blog main
san francisco blog main
science
susanna high
tc
vertex pharmaceuticals
What
diseases
2
×
drug
2
×
genetic
long
2
×
ability
accompanying
administration
ago
allowed
alzheimers
andme
andme’s
associated
biotechs
considering
consumers
data
dyne
early
expected
experimental
eyes
fda
finally
food
gave
genes
green
having
health
humans
including
information
ipo
ipos
late
light
medicines
moratorium
muscle
Language
unset
Current search:
long
×
diseases
×
drug
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@techcrunch.com
7 years ago
23andMe is finally allowed to tell you if you have the genes for Parkinsons
